Literature DB >> 12220799

Course of depression, health services costs, and work productivity in an international primary care study.

Gregory E Simon1, Daniel Chisholm, Michael Treglia, Donald Bushnell.   

Abstract

The Longitudinal Investigation of Depression Outcomes (LIDO) Study examined the outcomes and economic correlates of previously untreated depression among primary care patients in Barcelona, Spain; Be'er Sheva, Israel; Melbourne, Australia; Porto Alegre, Brazil; St. Petersburg, Russia; and Seattle, USA. Across all sites, 968 patients with current depressive disorder completed assessments of depression severity (Composite International Diagnostic Interview and Center for Epidemiologic Studies Depression Scale) at baseline and 9 months, and assessments of health services utilization and work days missed at baseline, 9 months, and 12 months. Follow-up depression status was characterized as persistent depression (n=345), partial remission (n=283), or full remission (n=340). At each site, patients with more favorable depression outcomes had fewer days missed from work; however, this relationship did not reach the 5% level of statistical significance at any site, and reached the 10% significance level only at Porto Alegre. Patients with more favorable depression outcomes also had lower health services costs, but this relationship reached the 5% significance level only in St. Petersburg. While the lack of statistical precision does not permit definitive conclusions, our findings are consistent with recent studies showing that recovery from depression is associated with lower health services costs and less time missed from work due to illness.

Entities:  

Mesh:

Year:  2002        PMID: 12220799     DOI: 10.1016/s0163-8343(02)00201-3

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  22 in total

Review 1.  Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment.

Authors:  Julie M Donohue; Harold Alan Pincus
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  The Relation Between Catastrophizing and Occupational Disability in Individuals with Major Depression: Concurrent and Prospective Associations.

Authors:  Heather Adams; Pascal Thibault; Tamra Ellis; Emily Moore; Michael Sullivan
Journal:  J Occup Rehabil       Date:  2017-09

3.  Obesity, depression, and health services costs among middle-aged women.

Authors:  Gregory E Simon; David Arterburn; Paul Rohde; Evette J Ludman; Jennifer A Linde; Belinda H Operskalski; Robert W Jeffery
Journal:  J Gen Intern Med       Date:  2011-06-28       Impact factor: 5.128

4.  [Costs and associated factors with optimal and suboptimal responses to the treatment of major depressive disorder].

Authors:  Antoni Sicras-Mainar; Jorge Mauriño; Luis Cordero; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda
Journal:  Aten Primaria       Date:  2012-07-11       Impact factor: 1.137

5.  Resource use and costs associated with patients treated for depression in primary care.

Authors:  P Sobocki; M Ekman; H Agren; I Krakau; B Runeson; B Mårtensson; B Jönsson
Journal:  Eur J Health Econ       Date:  2007-03

6.  Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis.

Authors:  Simon Gilbody; David Richards; Stephen Brealey; Catherine Hewitt
Journal:  J Gen Intern Med       Date:  2007-09-14       Impact factor: 5.128

7.  The comorbidity of diabetes mellitus and depression.

Authors:  Wayne J Katon
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

Review 8.  Depression as a predictor of work resumption following myocardial infarction (MI): a review of recent research evidence.

Authors:  Adrienne O'Neil; Kristy Sanderson; Brian Oldenburg
Journal:  Health Qual Life Outcomes       Date:  2010-09-06       Impact factor: 3.186

9.  Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.

Authors:  Howard G Birnbaum; Rym Ben-Hamadi; Paul E Greenberg; Matthew Hsieh; Jackson Tang; Camille Reygrobellet
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care.

Authors:  Antoni Sicras-Mainar; Jorge Maurino; Luis Cordero; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda
Journal:  Ann Gen Psychiatry       Date:  2012-08-03       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.